Skip to search formSkip to main contentSkip to account menu

Arlacel A

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

mannide monooleate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Evaluation of three oil-adjuvant vaccines against Pasteurella multocida in buffalo calves.
Three oil-adjuvant vaccines of Pasteurella multocida 6:B were evaluated with respect to the level and duration of the humoral… 
1989
1989
Preliminary studies on improved oil-adjuvant vaccine for haemorrhagic septicaemia in buffalo calves.
Summary: Two oil-adjuvant vaccines of Pasteurella multocida Robert's type 1 were prepared and evaluated for induction of an… 
1983
1983
The effectiveness of inactivated vaccines applied parenterally to sows to control Escherichia coli diarrhea in piglets in an industrial fattening farm.
1976
1976
Arthritogenicity of Mycobacterium smegmatis subfractions, related to different oil vehicle and different composition.
Arthrigenicity of Mycobacterium smegmatis subfractions appeared to be remarkably potentiated in oil vehicles such as squalane or… 
1974
1974
Repair of lesions induced in human liver cell DNA by N-nitroso compounds as measured by the bromodeoxyuridine photolysis method.
1974
1974
The release of solutes from the aqueous phase of mineral oil emulsions.
1971
1971
Fractionation of Arlacel A 1
Summary Mannide monooleate and mannide dioleate fractions were obtained by vacuum distillation and column chromatography of… 
1967
1967
Preparation and Effect of Different Adjuvants on the Immunogenic Activity of Mycobacterial Ribosomal Fraction
Several emulsified and two nonemulsified incomplete adjuvants were examined for their adjuvant activity by use of mycobacterial… 
1966
1966
Influence of Antigens on Release of Free Fatty Acids from Arlacel A (Mannide Monooleate)
Summary With use of the modified method of Dumcombe for assay of FFA, it was found that water-in-oil emulsified tetanus toxoids… 
1964
1964
NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. 3. EFFICACY AND TOXICITY STUDIES IN MAN.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)